Benzoylenurea

Benzoylenurea

SCHEMBL7420432

Clc1nc(Cl)c2ccccc2n1.O=c1[nH]c(=O)c2ccccc2[nH]1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.60
KDM4E B2RXH2 4/20 0.60
CA12 O43570 1/20 0.60
CA9 Q16790 1/20 0.60
TNKS2 Q9H2K2 5/20 0.43
GUSB P08236 4/20 0.43
TNKS O95271 3/20 0.43
PARP2 Q9UGN5 1/20 0.43
PDE10A Q9Y233 1/20 0.43
QTRT1 Q9BXR0 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
LMNA P02545 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41
BLM P54132 2/20 0.41
PMP22 Q01453 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoylenurea SCHEMBL29407209 0.78 KDM4E (1.00) PARP1KDM4ECA12CA9TNKS2
Benzoylenurea SCHEMBL37945 0.78 KDM4E (1.00) PARP1KDM4ECA12CA9TNKS2
SCHEMBL29389300 0.78 MAOA (0.56) KDM4ELMNAKMT2AALDH1A1HSD17B10
SCHEMBL92707 0.78 MAOA (0.56) KDM4ELMNAKMT2AALDH1A1HSD17B10
Benzoylenurea SCHEMBL5072763 0.76 KDM4E (0.95) PARP1KDM4ECA12CA9TNKS2
Benzoylenurea SCHEMBL29722891 0.76 KDM4E (0.95) PARP1KDM4ECA12CA9TNKS2
Benzoylenurea SCHEMBL30526893 0.76 KDM4E (0.95) PARP1KDM4ECA12CA9TNKS2
Bicarbonate SCHEMBL11023181 0.74 MAOA (0.48) KDM4EPDE10AKMT2AALDH1A1MEN1
Benzoylenurea SCHEMBL10765540 0.74 KDM4E (0.91) PARP1KDM4ECA12CA9TNKS2
Benzoylenurea SCHEMBL28539125 0.73 PARP1 (0.81) PARP1KDM4ECA12CA9TNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147091-A2 FUSED RING HETEROARYL AND HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2001-10-24 EP disclosed
WO-2000043371-A2 FUSED RING HETEROARYL AND HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2000-07-27 WO disclosed